In the News
Private AI and Replica Analytics announce partnership to tackle data privacy
Replica Analytics, an Aetion company, is partnering with data privacy software solutions developer Private AI. The partnership is a response to an urgent need for a privacy-preserving solution in healthcare and aims to provide a comprehensive solution for healthcare’s data privacy and security challenges. Replica...
Aster Insights Names Dr. Anand Shah as Chief Executive Officer
Aster Insights has announced the appointment of Dr. Anand Shah as chief executive officer, effective immediately. He succeeds Jim Gabriele, who has stepped down from his position. Gabriele and Shah have collaborated closely on a number of strategic, operational, and business development initiatives over the past six...
Komodo Health unveils MapEnhance, a new centralized network of specialty data partners
Komodo Health has recently launched MapEnhance, a feature that leverages a network of specialty data partners connecting into the company’s platform. MapEnhance builds on Komodo’s Healthcare Map, which it characterizes as a de-identified data set on 330 million patients in the United States, by combining it with data...
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
Twist Bioscience Corporation, a company that offers high-quality synthetic DNA using its silicon platform, along with Aster Insights, has announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620...
Clinical ink Announces New Continuous Glucose Monitoring Solution
Clinical Ink, a global life science technology company, now offers continuous glucose monitoring (CGM) within its integrated digital biomarker solution. The new modules enable remote collection, central storage, and analysis of sensor data from commercially available devices for use in diabetes clinical trials. The...
RCT-DUPLICATE Findings Demonstrate Capability of Real-World Evidence Studies to Reach Conclusions Similar to Randomized Clinical Trials
Real-world evidence (RWE) technology and analytics company Aetion has announced the culmination of the RCT-DUPLICATE demonstration project, with complete findings published in The Journal of the American Medical Association (JAMA). This three-year initiative tested whether researchers asking clinical questions in...
Inside the new world of healthcare data
In a recent episode of the PharmaPhorum podcast, Evidation co-CEO and Executive Chair of the Board Deborah Kilpatrick discussed healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research participants. The discussion began with data...
Replica Analytics unveils Replica Synthesis 3.0
Replica Analytics, an Aetion company, has released Replica Synthesis 3.0, its privacy- and utility-preserving synthetic data generation software that has been updated with an enhanced user experience. This makes it easier for analysts to train generative models and evaluate their utility and privacy. The company...
M2GEN Rebrands to Aster Insights
Bioinformatics company M2GEN has announced that it is rebranding, changing its name to Aster Insights. As the nexus between patients, researchers, and the life sciences industry, the company’s unique clinical and molecular dataset has enabled new insights for researchers and accelerated target identification and drug...
Through reverse auctions, Minnesota pushes for PBM savings and price transparency
Truveris has helped the State of Minnesota save more than $28 million in pharmacy benefits expenses over the next two years. Using the company’s technology, the state was able to evaluate bids from competing pharmacy benefit managers (PBMs). Truveris’ technology allows health plan sponsors to conduct reverse...